Orient EuroPharma Co., Ltd. (TPEX:4120)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
46.10
-1.60 (-3.35%)
Mar 26, 2026, 1:30 PM CST
Market Cap4.00B -17.7%
Revenue (ttm)4.60B +4.6%
Net Income-567.39M
EPS-6.54
Shares Out86.75M
PE Ration/a
Forward PEn/a
Dividend1.00 (2.10%)
Ex-Dividend Daten/a
Volume43,249
Average Volume47,642
Open47.70
Previous Close47.70
Day's Range46.10 - 48.40
52-Week Range40.05 - 58.90
Beta0.22
RSI53.48
Earnings DateMay 12, 2026

About Orient EuroPharma

Orient EuroPharma Co., Ltd., a pharmaceutical company, develops and manufactures drugs worldwide. Its prescription medicines include cardiovascular, metabolism, neurology, obstetrics and gynecology, respiratory, andrology, immunology, antibiotic, and anti-cancer drugs. The company also provides nutrition and baby care products, such as milk under the Karihome brand name; and healthcare supplements for liquid nutrition, regular blood lipids, l-arginines, agile movements, and improved sleep qualities under the Nutrifuel brand name. In addition, t... [Read more]

Sector Healthcare
Founded 1982
Employees 339
Stock Exchange Taipei Exchange
Ticker Symbol 4120
Full Company Profile

Financial Performance

In 2025, Orient EuroPharma's revenue was 4.60 billion, an increase of 4.64% compared to the previous year's 4.39 billion. Losses were -567.39 million, 99.8% more than in 2024.

Financial Statements